Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_assertion type Assertion NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_head.
- NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_assertion description "[Potentiation of AZT activation by the engineered TMPK expressed in the human prostate cancer cell line, PC-3, resulted in effective bystander killing of PC-3 cells lacking TMPK expression--an effect that could be blocked by the GJIC inhibitor, carbenoxolone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_provenance.
- NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_assertion evidence source_evidence_literature NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_provenance.
- NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_assertion SIO_000772 24194950 NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_provenance.
- NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_assertion wasDerivedFrom befree-2016 NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_provenance.
- NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_assertion wasGeneratedBy ECO_0000203 NP1125325.RAfJrrwnvMTLk2HWCLjVifxGX4eggkR83vm5eVZzQjRKs130_provenance.